GlaxoSmithKline (GSK) will pay $40.75 million to settle allegations brought by 38 attorneys general that the drug company and its subsidiary Pharmco Puerto Rico Inc engaged in deceptive practices when they distributed “adulterated” lots of the prescription drugs Kytril, Bactroban, Paxil CR and Avandamet in the United States between 2001 and 2004. Pharmco was one of GSK’s largest drug making facilities in the world and a major supplier of prescription drugs. The AGs accused the company of distributing medications to the United States that were poorly made and posed serious risks to people who used them. Pharmco Puerto Rico pled ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.